Dascena
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Dascena sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Dascena: 6 sponsored US clinical trials, none currently recruiting.
Dascena sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. The most-studied condition in this pipeline is Severe Sepsis, with 1 trials.
Upper-quartile sponsor footprint
Dascena sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
Classification of COVID-19 Infection in Posteroanterior Chest X-rays
NCT04358536
COVID-19 Mortality Prediction Model
NCT04358510
Respiratory Decompensation and Model for the Triage of COVID-19 Patients
NCT04390516
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
NCT04423991
Predictive algoRithm for EValuation and Intervention in SEpsis
NCT03235193
An Algorithm Driven Sepsis Prediction Biomarker
NCT03015454
Therapeutic Areas
How the Dascena archive is shaped
6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Severe Sepsis (1 trial), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Dascena: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Dascena sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Dascena page
6 registered trials is a research-attention snapshot, not an endorsement of Dascena or any single study.
- None of Dascena's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Severe Sepsis is the condition Dascena studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Severe Sepsis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dascena pipeline card: 6 registered trials from official public datasets.Report a data error.